Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome

Jason K. Russell; Zinayida Schlachetzki; Beau M. Ances; Michael S. Rafii

doi:10.1001/jamaneurol.2025.5261

Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome

Jason K. Russell
, Zinayida Schlachetzki
, Beau M. Ances
, Michael S. Rafii

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

This cross-sectional study examines data for participants in the Alzheimer Biomarker Consortium–Down Syndrome study to gauge the concordance of clinical and biological Alzheimer disease staging.

Original language	English
Pages (from-to)	294-296
Number of pages	3
Journal	JAMA Neurology
Volume	83
Issue number	3
DOIs	https://doi.org/10.1001/jamaneurol.2025.5261
State	Published - Mar 9 2026

Access to Document

10.1001/jamaneurol.2025.5261

Cite this

@article{a4f430fd9ff4424bb8726cfe5a62320d,

title = "Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome",

abstract = "This cross-sectional study examines data for participants in the Alzheimer Biomarker Consortium{\textendash}Down Syndrome study to gauge the concordance of clinical and biological Alzheimer disease staging.",

author = "Russell, \{Jason K.\} and Zinayida Schlachetzki and Ances, \{Beau M.\} and Rafii, \{Michael S.\}",

note = "Publisher Copyright: {\textcopyright} 2026 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies. American Medical Association.",

year = "2026",

month = mar,

day = "9",

doi = "10.1001/jamaneurol.2025.5261",

language = "English",

volume = "83",

pages = "294--296",

journal = "JAMA Neurology",

issn = "2168-6149",

number = "3",

}

TY - JOUR

T1 - Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome

AU - Russell, Jason K.

AU - Schlachetzki, Zinayida

AU - Ances, Beau M.

AU - Rafii, Michael S.

PY - 2026/3/9

Y1 - 2026/3/9

N2 - This cross-sectional study examines data for participants in the Alzheimer Biomarker Consortium–Down Syndrome study to gauge the concordance of clinical and biological Alzheimer disease staging.

AB - This cross-sectional study examines data for participants in the Alzheimer Biomarker Consortium–Down Syndrome study to gauge the concordance of clinical and biological Alzheimer disease staging.

UR - https://www.scopus.com/pages/publications/105028191737

U2 - 10.1001/jamaneurol.2025.5261

DO - 10.1001/jamaneurol.2025.5261

M3 - Article

C2 - 41525055

AN - SCOPUS:105028191737

SN - 2168-6149

VL - 83

SP - 294

EP - 296

JO - JAMA Neurology

JF - JAMA Neurology

IS - 3

ER -

Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome

Abstract

Access to Document

Other files and links

Fingerprint

Cite this